Researchers combined electronic sensors with human islet cells to create living ‘cyborg’ organoids transmitting troves of ...
4d
‘Bodyguard’ therapy to address type 1 diabetes at MUSC seeks to protect insulin-producing cells
It started with basic insights from pregnancy but an MUSC researcher is seeking to manipulate immune cells to protect insulin ...
(RTTNews) - Genprex Inc. (GNPX) reported positive preliminary preclinical results for its diabetes gene-therapy candidate GPX-002, showing in-vivo proof-of-concept in both Type 2 diabetic non-human ...
People with type 1 diabetes must constantly rely on insulin injections or pumps, usually for the rest of their life after diagnosis. The autoimmune disease destroys the cells that produce the hormone, ...
In the battle against type 1 diabetes (T1D), one researcher at the Medical University of South Carolina (MUSC) is leading a bold new front. With $1 million in funding from Breakthrough T1D, the ...
Funding will support clinical development of EPF-001, a first-in-class G9a inhibitor for sickle cell disease and beta thalassemia Company built on pioneering research from RIKEN and Tokyo University ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results